Sensorion【ALSEN】銘柄情報

Sensorion (ALSEN) 銘柄情報

リアルタイムのディスカッションと取引のアイデア: 当社の強力なプラットフォームで自信を持って取引できます。

プレミアム

通貨

0.2575

( 11.47% )

買値

0.25

売値

0.2615

出来高

2,736,458

0.231 日の範囲 0.2635

0.226 52 週間の範囲 0.77

時価総額

132.54M

前日終値

0.231

始値

0.233

時刻

1549

0.2575

最終取引時間

財務取引量

VWAP

平均取引量 (3 か月)

2,697,961 €

発行済株式数

514,719,712

配当利回り

PER

-2.55

1 株当たり利益 (EPS)

-0.1

歳入

5.81M

純利益

-29.43M

Sensorion SA, a biotechnology company, engages in the development of novel therapies to restore, treat, and prevent hearing loss disorders in France. The company develops SENS-501, a dual AAV vector gene therapy development product for restoring hearing in patients with mutations in OTOF gene in Pha... Sensorion SA, a biotechnology company, engages in the development of novel therapies to restore, treat, and prevent hearing loss disorders in France. The company develops SENS-501, a dual AAV vector gene therapy development product for restoring hearing in patients with mutations in OTOF gene in Phase 1/2 clinical trials; and SENS-601, a candidate for the treatment of hearing loss caused by mutations of the GJB2 gene in preclinical studies. It is also developing SENS-40, a small molecule in Phase 2b clinical trials to treat sudden sensorineural hearing loss; prevention of residual hearing loss following cochlear implantation in Phase 2a clinical trials; and prevention of cisplatin-induced ototoxicity in Phase 2a clinical trials. The company was incorporated in 2009 and is headquartered in Montpellier, France. 詳細を表示

セクター

Healthcare

業界

Biotechnology & Life Sciences

ウェブサイト

www.sensorion.com

本社

Montpellier, France

設立

2026

Sensorion is listed in the Healthcare sector of the ユーロネクスト with ticker ALSEN. The last closing price for Sensorion was 0.23 €. Over the last year, Sensorion shares have traded in a share price range of 0.226 € to 0.77 €.

Sensorion currently has 514,719,712 shares in issue. The market capitalisation of Sensorion is 132.54 € million. Sensorion has a price to earnings ratio (PE ratio) of -2.55.

Sensorion Announces its Participation in the 60th Annual Inner Ear Biology Workshop

Regulatory News: Sensorion (FR0012596468 – ALSEN) a pioneering clinical-stage biotechnology company specializing in the development of novel...

Sensorion annonce l’augmentation des moyens affectés au contrat de liquidité avec Kepler Cheuvreux

Regulatory News : Sensorion (FR0012596468 – ALSEN), société pionnière de biotechnologie au stade clinique, spécialisée dans le développement de...

Sensorion Announces Its Participation In Upcoming Investor Conferences

Regulatory News: Sensorion (FR0012596468 – ALSEN) a pioneering clinical-stage biotechnology company specializing in the development of novel...

Sensorion Completes Patient Enrollment of the Second Cohort in Audiogene Phase 1/2 Gene Therapy Clinical Trial

Regulatory News: Sensorion (FR0012596468 – ALSEN), a pioneering clinical-stage biotechnology company specializing in the development of novel...

Sensorion annonce des données préliminaires positives de la première cohorte de l'essai clinique de Phase 1/2 de thérapie génique Audiogene

Le candidat de thérapie génique SENS-501, ainsi que la procédure chirurgicale, présentent un bon profil de sécurité chez tous les patients...

期間 †	前日比	前日比 %	始値	高値	安値	平均出来高	VWAP
1	-0.035	-11.9658119658	0.2925	0.2935	0.226	2282353	0.24977854	DE
4	-0.133	-34.0588988476	0.3905	0.4435	0.226	2280971	0.32448623	DE
12	-0.1225	-32.2368421053	0.38	0.45	0.226	2073788	0.35924832	DE
26	-0.0845	-24.7076023392	0.342	0.77	0.226	2505601	0.39870182	DE
52	-0.1025	-28.4722222222	0.36	0.77	0.226	1567457	0.39020986	DE
156	-0.0825	-24.2647058824	0.34	1.04	0.1544	538487	0.40701052	DE
260	-1.7425	-87.125	2	2.29	0.1544	342314	0.45445896	DE